HSCS (HeartSciences) Other Operating Expense: $-0.00 Mil (TTM As of Jan. 2026)


HSCS HeartSciences Inc HSCS
48 GF Score
Price $2.75
GF Value $2.59
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is HeartSciences Other Operating Expense?

HeartSciences HSCS +0.74% 48 Other Operating Expense is $-0.00 Mil as of Jan. 2026. GuruFocus rates HSCS with a GF Score™ of 48/100 and a GF Value™ of $2.59 (Fairly Valued). The stock has 7 warning signs investors should review.

HeartSciences's Other Operating Expense for the three months ended in Jan. 2026 was $0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jan. 2026 was $-0.00 Mil.

HeartSciences's quarterly Other Operating Expense declined from Jul. 2025 ($0.00 Mil) to Oct. 2025 ($-0.00 Mil) but then increased from Oct. 2025 ($-0.00 Mil) to Jan. 2026 ($0.00 Mil).

HeartSciences's annual Other Operating Expense declined from Apr. 2023 ($0.00 Mil) to Apr. 2024 ($0.00 Mil) but then increased from Apr. 2024 ($0.00 Mil) to Apr. 2025 ($0.00 Mil).

HeartSciences Other Operating Expense Historical Data

* Premium members only.

The historical data trend for HeartSciences's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartSciences Other Operating Expense Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Other Operating Expense
Get a 7-Day Free Trial 0.00 -0.00 0.00 0.00 0.00

HeartSciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 -0.00 0.00
HSCS
48GF Score
HeartSciences Inc HSCS
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartSciences Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $-0.00 Mil mean?
HeartSciences (HSCS) has a Other Operating Expense of $-0.00 Mil as of Jan. 2026. Other operating expenses that a company records on its income statement. View historical data on HeartSciences and its competitors.
Is HeartSciences' Other Operating Expense too high?
HeartSciences' current Other Operating Expense is $-0.00 Mil. Overall, HeartSciences has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HeartSciences' Other Operating Expense compare to CSDX and CODX?
HeartSciences' Other Operating Expense of $-0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on HeartSciences and its competitors. HeartSciences's current Other Operating Expense is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartSciences stock overvalued right now?
Based on GuruFocus' analysis, HeartSciences (HSCS) is currently considered Fairly Valued. The stock's GF Value™ is $2.59, compared to a current price of $2.75 — trading 6.2% above its estimated fair value. The current Other Operating Expense is $-0.00 Mil. HeartSciences' overall GF Score™ is 48/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For HeartSciences (HSCS), the current Other Operating Expense is $-0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HeartSciences (HSCS) Overvalued in 2026?

Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued. The current stock price of $2.75 is trading 6.2% above its estimated GF Value™ of $2.59. GuruFocus considers HeartSciences to be Fairly Valued.

Key valuation signals for HSCS:

  • Other Operating Expense: $-0.00 Mil
  • GF Value™: $2.59 vs. price of $2.75 (6.2% above fair value)
  • GF Score™: 48/100 with 7 warning signs

No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HeartSciences Business Description

Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
48GF Score

Get the complete analysis for HSCS

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.75
Price
$2.59
GF Value